Area of research
Immunology · Oncology
Research interest
Research interests include Immune cells in cancer, Cancer Immunotherapy and Biomarkers, Ovarian cancer diagnosis and treatment, and Cancer-related molecular mechanisms research.
2774P DAREON®-9: A phase Ib open-label dose escalation and dose confirmation study of obrixtamig (BI 764532) plus topotecan in patients (pts) with advanced small-cell lung cancer (SCLC): Updated results
TRPML1 triggers ferroptosis defense and is a potential therapeutic target in AKT-hyperactivated cancer
Tubastatin A potently inhibits GPX4 activity to potentiate cancer radiotherapy through boosting ferroptosis
Analysis of risk factors of precocious puberty in children
The potential health effects associated with electronic-cigarette
Correction: Analysis of risk factors of precocious puberty in children
FUT8-mediated aberrant N-glycosylation of B7H3 suppresses the immune response in triple-negative breast cancer
Fis1 phosphorylation by Met promotes mitochondrial fission and hepatocellular carcinoma metastasis
Disruption of super-enhancer-driven tumor suppressor gene RCAN1.4 expression promotes the malignancy of breast carcinoma
1434P A prospective, multicenter, non-randomized, controlled trial of apatinib plus perioperative chemotherapy with FLOT protocol and surgery for the treatment of stage III gastric cancer
Regorafenib Promotes Antitumor Immunity via Inhibiting PD-L1 and IDO1 Expression in Melanoma